Regulation of airway and alveolar epithelial cell apoptosis by p53-induced plasminogen activator inhibitor-1 during cigarette smoke exposure injury

American Journal of Respiratory Cell and Molecular Biology

Volumn 47, Issue 4, 2012, Pages 474-483

  Shetty, Shwetha K ^a   Bhandary, Yashodhar P ^a   Marudamuthu, Amarnath S ^a   Abernathy, Daniel ^a   Velusamy, Thirunavukkarasu ^a   Starcher, Barry ^b   Shetty, Sreerama ^a  

^a Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

ATII cell apoptosis; Caveolin 1 scaffolding domain peptide; Cigarette smoke; Lung epithelial injury

Indexed keywords

CAVEOLIN 1 SCAFFOLDING DOMAIN PEPTIDE; CIGARETTE SMOKE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL XL; PROTEIN P53; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ATTENUATION; CELL CULTURE; CELL DAMAGE; CELL PROTECTION; CELL TYPE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; MOUSE; NONHUMAN; PASSIVE SMOKING; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; WILD TYPE;

ANIMALS; APOPTOSIS; BRONCHOALVEOLAR LAVAGE FLUID; CAVEOLIN 1; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; LUNG; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PNEUMOCYTES; RESPIRATORY MUCOSA; RNA STABILITY; SMOKE; TOBACCO; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

MUS;

EID: 84866988824     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2011-0390OC     Document Type: Article

References (38)

1. MacNee W, Rahman I. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:S58-S65.
2. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:50-60. (Pubitemid 40562963)
3. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, Black S, Shinefield H, Fukuda K. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000;342:232-239. (Pubitemid 30058954)
4. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. Influenza-associated hospitalizations in the united States. JAMA 2004;292:1333-1340. (Pubitemid 39223224)
5. Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 1998;53:129-136. (Pubitemid 28212140)
6. Juhan-Vague I, Moerman B, De Cock F, Aillaud MF, Collen D. Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions. Thromb Res 1984;33:523-530. (Pubitemid 14166345)
7. Kruithof EK, Gudinchet A, Bachmann F. Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states. Thromb Haemost 1988;59:7-12. (Pubitemid 18053642)
8. Okudela K, Ito T, Mitsui H, Hayashi H, Udaka N, Kanisawa M, Kitamura H. The role of p53 in bleomycin-induced DNA damage in the lung: a comparative study with the small intestine. Am J Pathol 1999;155:1341-1351. (Pubitemid 29488941)
9. Simpson AJ, Gray RS, Moore NR, Booth NA. The effects of chronic smoking on the fibrinolytic potential of plasma and platelets. Br J Haematol 1997;97:208-213. (Pubitemid 27179589)
10. Shetty S, Shetty P, Idell S, Velusamy T, Bhandary YP, Shetty RS. Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53. J Biol Chem 2008;283:19570-19580.
11. Kortlever RM, Higgins PJ, Bernards R. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat Cell Biol 2006;8:877-884.
12. Shetty S, Gyetko MR, Mazar AP. Induction of p53 by urokinase in lung epithelial cells. J Biol Chem 2005;280:28133-28141. (Pubitemid 41076932)
13. Corti M, Brody AR, Harrison JH. Isolation and primary culture of murine alveolar type II cells. Am J Respir Cell Mol Biol 1996;14:309-315. (Pubitemid 126440495)
14. Carp H, Janoff A. Possible mechanisms of emphysema in smokers: in vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. Am Rev Respir Dis 1978;118:617-621. (Pubitemid 9027203)
15. Shetty S, Velusamy T, Idell S, Tang H, Shetty PK. Regulation of urokinase receptor expression by protein tyrosine phosphatases. Am J Physiol Lung Cell Mol Physiol 2007;292:L414-L421.
16. Shetty S, Bhandary YP, Shetty SK, Velusamy T, Shetty P, Bdeir K, Gyetko MR, Cines DB, Idell S, Neuenschwander PF, et al. Induction of tissue factor by urokinase in lung epithelial cells and in the lungs. Am J Respir Crit Care Med 2010;181:1355-1366.
17. Bhandary YP, Velusamy T, Shetty P, Shetty RS, Idell S, Cines DB, Jain D, Bdeir K, Abraham E, Tsuruta Y, et al. Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide- induced acute lung injury. Am J Respir Crit Care Med 2009;179:288-298.
18. Shetty S, Bdeir K, Cines DB, Idell S. Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells. J Biol Chem 2003;278:18124-18131. (Pubitemid 36799426)
19. Kunz C, Pebler S, Otte J. von der Ahe D. Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. Nucleic Acids Res 1995;23:3710-3717.
20. Bhandary YP, Shetty SK, Marudamuthu AS, Gyetko MR, Idell S, Gharaee-Kermani M, Shetty RS, Starcher BC, Shetty S. Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system. Am J Physiol Lung Cell Mol Physiol 2012;302:L463-L473.
21. Mulcahy M, Byrne MA, Ruprecht A. How does the Irish smoking ban measure up? A before and after study of particle concentrations in Irish pubs. Proceedings: Indore Air 2005;15:1659-1662.
22. Foronjy RF, Mercer BA, Maxfield MW, Powell CA, Armiento JD. Structural emphysema does not correlate with lung compliance: lesson from the mouse smoking model. Exp Lung Res 2005;31:547-562. (Pubitemid 40967241)
23. Morrow SAM, Lauer T, Collaco JM, Yee M, Reilly MO, Mitzner W, Neptune E, Wise R, Biswal S. Neonatal hyperoxia contributes additively to cigarette smoke-induced chronic obstructive pulmonary disease changes in adult mice. Am J Respir Cell Mol Biol 2011;45:610-616.
24. Fujihara M, Nagai N, Sussan TE, Biswal S, Handa JT. Chronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice. PLoS ONE 2008;3:e3119.
25. Simet SM, Sisson JH, Pavlik JA, Devasure JM, Boyer C, Liu X, Kawasaki S, Sharp JG, Rennard SI, Wyatt TA. Long term cigarette smoke exposure in a mouse model of ciliated epithelial cell function. Am J Respir Cell Mol Biol 2010;43:635-640.
26. Basu A, Haldar S. The relationship between bcI2, bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod 1998;4:1099-1109. (Pubitemid 28552792)
27. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. Tumor suppressor P53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799-1805. (Pubitemid 24163411)
28. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80:293-299.
29. Chiou SK, Rao L, White E. Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 1994;14:2556-2563. (Pubitemid 24108238)
30. Staversky RJ, Vitiello PF, Yee M, Callahan LM, Dean DA, O'Reilly MA. Epithelial ablation of bcl-xl increases sensitivity to oxygen without disrupting lung development. Am J Respir Cell Mol Biol 2010;43:376-385.
31. Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/akt pathway. Proc Natl Acad Sci USA 1999;96:4240-4245. (Pubitemid 29190320)
32. Wan X, Helman LJ. Levels of PTEN protein modulate akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells. Oncogene 2003;22:8205-8211. (Pubitemid 37487311)
33. Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/akt pathway. Proc Natl Acad Sci USA 1998;95:15587-15591. (Pubitemid 29018743)
34. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase akt pathway in human cancer. Nat Rev Cancer 2002;2:489-501. (Pubitemid 37328931)
35. Georgescu MM. PTEN tumor suppressor network in PI3K-Akt pathway control. Genes Cancer 2010;1:1170-1177.
36. Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, Lesche R, Whale AD, Martinez-Diaz H, Rozengurt N, Cardiff RD, et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 2003;3:117-130. (Pubitemid 37443385)
37. Balsara RD, Castellino FJ, Ploplis VA. A novel function of plasminogen activator inhibitor-1 in modulation of the AKT pathway in wild-type and plasminogen activator inhibitor-1-deficient endothelial cells. J Biol Chem 2006;281:22527-22536.
38. Shetty S. Regulation of urokinase receptor mRNA stability by hnRNP C in lung epithelial cells. Mol Cell Biochem 2005;272:107-118. (Pubitemid 40867371)